Invention Grant
US09062124B2 GIP-based mixed agonists for treatment of metabolic disorders and obesity
有权
用于治疗代谢紊乱和肥胖的基于GIP的混合激动剂
- Patent Title: GIP-based mixed agonists for treatment of metabolic disorders and obesity
- Patent Title (中): 用于治疗代谢紊乱和肥胖的基于GIP的混合激动剂
-
Application No.: US12999285Application Date: 2009-06-16
-
Publication No.: US09062124B2Publication Date: 2015-06-23
- Inventor: Richard D. Dimarchi , Tao Ma
- Applicant: Richard D. Dimarchi , Tao Ma
- Applicant Address: US IN Indianapolis
- Assignee: Indiana University Research and Technology Corporation
- Current Assignee: Indiana University Research and Technology Corporation
- Current Assignee Address: US IN Indianapolis
- Agency: Barnes & Thornburg LLP
- International Application: PCT/US2009/047447 WO 20090616
- International Announcement: WO2010/011439 WO 20100128
- Main IPC: A61K38/26
- IPC: A61K38/26 ; C07K14/605
Abstract:
Glucagon peptides that exhibit GIP agonist activity in addition to glucagon and/or GLP-I activity are provided. Pharmaceutical compositions comprising such glucagon peptides and therapeutic methods of using such peptides are also provided.
Public/Granted literature
- US20110166062A1 GIP-BASED MIXED AGONISTS FOR TREATMENT OF METABOLIC DISORDERS AND OBESITY Public/Granted day:2011-07-07
Information query
IPC分类:
